Morpholine as ubiquitous pharmacophore in medicinal chemistry: Deep insight into the structure-activity relationship (SAR)

被引:143
|
作者
Kumari, Archana [1 ,3 ]
Singh, Rajesh K. [2 ]
机构
[1] Rayat Bahra Inst Pharm, Dept Pharmaceut Chem, Nangal Shahidan 146104, Punjab, India
[2] Shivalik Coll Pharm, Dept Pharmaceut Chem, Nangal 140126, Punjab, India
[3] IK Gujral Punjab Tech Univ, Fac Pharm, Jalandhar, Punjab, India
关键词
Morpholine; Pharmacophore; Structure-activity relationship (SAR); Pharmacokinetic; Pharmacological profile; DEPENDENT PROTEIN-KINASE; PHOSPHATIDYLINOSITOL 3-KINASE PI3K; IN-VITRO METABOLISM; (PI3K)/MAMMALIAN TARGET; BIOLOGICAL EVALUATION; SELECTIVE INHIBITOR; ASYMMETRIC-SYNTHESIS; ANTIFUNGAL AGENTS; MAMMALIAN TARGET; SCHIFF-BASES;
D O I
10.1016/j.bioorg.2020.103578
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Morpholine is a versatile moiety, a privileged pharmacophore and an outstanding heterocyclic motif with wide ranges of pharmacological activities due to different mechanisms of action. The ability of morpholine to enhance the potency of the molecule through molecular interactions with the target protein (kinases) or to modulate the pharmacokinetic properties propelled medicinal chemists and researchers to synthesize morpholine ring by the efficient ways and to incorporate this moiety to develop various lead compounds with diverse therapeutic activities. The present review primarily focused on discussing the most promising synthetic leads containing morpholine ring along with structure-activity relationship (SAR) to reveal the active pharmacophores accountable for anticancer, anti-inflammatory, antiviral, anticonvulsant, antihyperlipidemic, antioxidant, antimicrobial and antileishmanial activity. This review outlines some of the recent effective chemical synthesis for morpholine ring. The review also highlighted the metabolic liability of some clinical drugs containing this nucleus and various researches on modified morpholine to enhance the metabolic stability of drugs as well. Drugs bearing morpholine ring and those under clinical trials are also mentioned with the role of morpholine and their mechanism of action. This review will provide the necessary knowledge base to the medicinal chemists in making strategic structural changes in designing morpholine derivatives.
引用
收藏
页数:33
相关论文
共 50 条
  • [1] Medicinal chemistry perspective on the structure-activity relationship of stilbene derivatives
    Sepehri, Saghi
    Khedmati, Mina
    Yousef-Nejad, Faeze
    Mahdavi, Mohammad
    RSC ADVANCES, 2024, 14 (28) : 19823 - 19879
  • [2] Chemistry and Therapeutic Aspect of Triazole: Insight into the Structure-activity Relationship
    Sharma, Shikha
    Mittal, Nitin
    Banik, Bimal Krishna
    CURRENT PHARMACEUTICAL DESIGN, 2023, 29 (34) : 2702 - 2720
  • [3] A Profound Insight into the Structure-activity Relationship of Ubiquitous Scaffold Piperazine: An Explicative Review
    Chaudhary, Jasmine
    Sharma, Vishal
    Jain, Akash
    Sharma, Diksha
    Chopra, Bhawna
    Dhingra, Ashwani K.
    MEDICINAL CHEMISTRY, 2024, 20 (01) : 17 - 29
  • [4] Synthesis, structure-activity relationship and pharmacophore of eleutherobin
    Diederichsen, U
    NACHRICHTEN AUS CHEMIE TECHNIK UND LABORATORIUM, 1999, 47 (10): : 1228 - +
  • [5] Arylidene indanone scaffold: medicinal chemistry and structure-activity relationship view
    Menezes, Jose C. J. M. D. S.
    RSC ADVANCES, 2017, 7 (15): : 9357 - 9372
  • [6] Anticancer potential of indirubins in medicinal chemistry: Biological activity, structural modification, and structure-activity relationship
    Wang, Hezhen
    Wang, Zhiyuan
    Wei, Chunyong
    Wang, Jing
    Xu, Yingshu
    Bai, Guohui
    Yao, Qizheng
    Zhang, Lei
    Chen, Yongzheng
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 223
  • [7] Morpholine as a privileged structure: A review on the medicinal chemistry and pharmacological activity of morpholine containing bioactive molecules
    Kourounakis, Angeliki P.
    Xanthopoulos, Dimitrios
    Tzara, Ariadni
    MEDICINAL RESEARCH REVIEWS, 2020, 40 (02) : 709 - 752
  • [8] STRUCTURE-ACTIVITY RELATIONSHIP (SAR) OF CURARIZING DRUGS
    LOEWE, S
    HARVEY, SC
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1951, 101 (01): : 23 - 23
  • [9] PubChem structure-activity relationship (SAR) clusters
    Kim, Sunghwan
    Han, Lianyi
    Yu, Bo
    Haehnke, Volker D.
    Bolton, Evan E.
    Bryant, Stephen H.
    JOURNAL OF CHEMINFORMATICS, 2015, 7
  • [10] PubChem structure-activity relationship (SAR) clusters
    Kim, Sunghwan
    Han, Lianyi
    Bolton, Evan E.
    Bryant, Stephen H.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 246